Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: Mesencephalic dopaminergic neurons

Journal of Comparative Neurology

Volumn 390, Issue 1, 1998, Pages 91-101

  Counihan, Timothy J ^a   Landwehrmeyer, G Bernhard ^b   Standaert, David G ^a   Kosinski, Christoph M ^a   Scherzer, Clemens R ^a   Daggett, Lorrie P ^c   Veliçelebi, Gönül ^c   Young, Anne B ^a   Penney Jr , John B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Excitotoxicity; In situ hybridization; NMDA; Parkinson's disease; Receptor subtypes

Indexed keywords

MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ADULT; AGED; ARTICLE; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031951010     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19980105)390:1<91::AID-CNE8>3.0.CO;2-L     Document Type: Article

References (59)

1. Albin, R.L., and J.T. Greenamyre (1992) Alternative excitotoxic hypothesis. Neurology 42:733-738.
2. Arias, M.J., F.D. Martinez, and J. Aceves (1992) Glutamate stimulation of tyrosine hydroxylase is mediated by NMDA receptors in the rat striatum. Brain Res. 569:317-322.
3. Ball, E., P. Shaw, P. Ince, and M. Johnson (1994) The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: A quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate. Brain Res. 658:209-218.
4. Beal, M.F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:357-366.
5. Bergman, H., T. Wichmann, and M. DeLong (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436-1438.
6. Bogerts, B. (1981) A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J. Comp. Neurol. 197:63-80.
7. Brotchie, J., I. Mitchell, M. Sambrook, and A. Crossman (1991) Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov. Disord. 6:133-138.
8. Brouillet, E., and M. Beal (1993) NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. Neuroreport 4:387-390.
9. Buller, A.L., H.C. Larson, B.E. Schneider, J.A. Beaton, R.A. Morrisett, and D.T. Monaghan (1994) The molecular basis of NMDA receptor subtypes: Native receptor diversity is predicted by subunit composition. J. Neurosci. 14:5471-5484.
10. Choi, D.W., and S.M. Rothman (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:171-182.
11. Christoffersen, C., and L. Meltzer (1995) Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: Possible preferential role for N-methyl-D-aspartate receptors. Neuroscience 67:373-381.
12. Difazio, M.C., Z. Hollingsworth, A.B. Young, and J.B. Penney (1992) Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology 42:402-406.
13. Dubach, M., R. Schmidt, D. Kunkel, D.M. Bowden, R. Martin, and D.C. German (1987) Primate neostriatal neurons containing tyrosine hydroxylase: Immunohistochemical evidence. Neurosci. Lett. 75:205-210.
14. Fearnley, J., and A. Lees (1991) Ageing and Parkinson's disease; substantia nigra regional selectivity. Brain 114:2283-2301.
15. Fischer, G., A. Bourson, J. Kemp, and H. Lorez (1996) The neuroprotective activity of RO 25-6981, a NMDA receptor NR2B subtype selective blocker. Soc. Neurosci. Abstr. 22:1760.
16. Foldes, R.L. (1994) Cloning and sequence analysis of additional splice variants encoding human N-methyl-D-aspartate receptor (NR1) subunits. Gene 147:303-304.
17. Gibb, W.R.G., and A.J. Lees (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psych. 54:388-396.
18. Grant, E., B. Backsai, L. Kricka, D. Pleasure, and D. Lynch (1996) Heteromeric NMDA receptor calcium responses are subunit dependent in transfected HEK-293 cells. Soc. Neurosci. Abstr. 22:68.
19. Greenamyre, J.T., and C.F. O'Brien (1991) N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch. Neurol. 48:977-981.
20. Grima, B., L. A., F. Blanot, N. Biguet, and J. Mallet (1985) Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl. Acad. Sci. USA 82:617-621.
21. Grima, B., A. Lamouroux, C. Boni, J.-F. Julien, F. Javoy-Agid, and J. Mallet (1987) A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326:707-711.
22. Hess, S.D., L.P. Daggett, J. Crona, C. Deal, C.-C. Lu, A. Urrutia, L. Chavez-Noriega, S.B. Ellis, E.C. Johnson, and G. Veliçelebi (1996) Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 278:808-816.
23. Hirsch, E., A. Graybiel, and Y. Agid (1988) Melanized dopaminergic neurons are differentially susceptable to degeneration in Parkinson's disease. Nature 334:345-348.
24. Hollmann, M., and S. Heinemann (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17:31-108.
25. Ikeda, K., K. Araki, C. Takayama, Y. Inoue, T. Yagi, S. Aizawa, and M. Mishina (1995) Reduced spontaneous activity of mice defective in the e4 subunit of the NMDA receptor channel. Mol. Brain Res. 33:61-71.
26. Ishii, T., K. Moriyoshi, H. Sugihara, K. Sakurada, H. Kadotani, M. Yokoi, C. Akazawa, R. Shigemoto, N. Mizuno, M. Masu, and S. Nakanishi (1993) Molecular characterization of the family of N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268:2836-2843.
27. Johnson, S., V. Seutin, and R. North (1992) Burst-firing in dopamine neurons induced by N-methyl-D-aspartate: Role of the electrogenic sodium pump. Science 258:665-667.
28. Karp, S.A., M. Masu, T. Eki, K. Ozawa, and S. Nakanishi (1993) Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-D-aspartate receptor. J. Biol. Chem. 268:3728-3733.
29. Kish, S.J., K. Shannak, and O. Hornykiewicz (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: Pathophysiologic and clinical implications. N. Engl. J. Med. 318:876-880.
30. Kosinski, C.M., D.G. Stomdaert, T.J. Counihan, C.R. Scherzer, J.A. Kerner, L.P. Daggett, G. Veliçelebi, J.B. Penney, Jr., A.B. Young, and G.B. Landwehrmeyer (1997) Expression of N-Methyl-D-Aspartate Receptor Subunit mRNAs in the Human Brain: Striatum and Globus Pallidus. J. Comp. Neuro. 390:63-74.
31. Krebs, M.-O., F. Trovero, M. Desban, C. Gauchy, J. Glowinsky, and M.-L. Kemel (1991) Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome and matrix-enriched areas of the rat striatum. J. Neurosci.11:1256-1262.
32. Kutsuwada, T., N. Kashiwabuchi, H. Mori, K. Sakimura, E. Kushiya, K. Araki, H. Meguro, H. Masaki, T. Kumanishi, and M. Arakawa (1992) Molecular diversity of the NMDA receptor channel. Nature 358:36-41.
33. Landwehrmeyer, G.B., D.G. Standaert, C.M. Testa, J.B. Penney, and A.B. Young (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:5297-5307.
34. Laurie, D.J., and P.H. Seeburg (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268:335-345.
35. Leuba, G., N. Jeanpretre, R. Kraftsik, and J.-M. Fritschy (1989) Sample size and statistical power in the hierarchical analysis of variance: Applications in morphometry of the nervous system. J. Neurosci. Meth. 29:231-239.
36. Loeschmann, P.-A., U. Wullner, J. Schulz, G. Fischer, J. Kemp, and T. Klockgether (1996) Antiparkinsonian activity of the NMDA2B antagonist RO 25-6981 in rats. Soc. Neurosci. Abstr. 22:721.
37. Marey-Semper, I., M. Gelman, and M. Lévi-Strauss (1995) A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 15:5912-5918.
38. 28-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience 65:87-91.
39. Monyer, H., N. Burnashev, D.J. Laurie, B. Sakmann, and P.H. Seeburg (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
40. Mori, H., and M. Mishina (1995) Structure and function of the NMDA receptor channel. Neuropharmacology 34:1219-1237.
41. Nakanishi, S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603.
42. Olszewski, J., and D. Baxter (1954) Cytoarchitecture of the Human Brainstem. Basel: S. Karger, pp. 52-58.
43. Overton, P., and D. Clarke (1992) Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst-firing in A9 dopamine neurons in the rat. Synapse 10:131-140.
44. Paquet, M., M. Tremblay, J.-J. Soghomonian, and Y. Smith (1997) AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: An immunohistochemical and in situ hybridization study. J. Neurosci. 17:1377-1396.
45. Pearson, J., M. Goldstein, K. Markey, and L. Brandeis (1983) Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3-32.
46. Planells-Cases, R., W. Sun, A.V. Ferrer-Montiel, and M. Montai (1993) Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain. Proc. Natl. Acad. Sci. USA 90:5057-5061.
47. Sitzmann, J.H., and P.K. LeMotte (1993) Rapid and efficient generation of PCR-derived riboprobe templates for in situ hybridization histochemistry. J. Histochem. Cytochem. 41:773-776.
48. Standaert, D.G., G.B. Landwehrmeyer, J.A. Kerner, J.B. Penney, and A.B. Young (1996) Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex, and hippocampus. Mol. Brain Res. 42:89-102.
49. Standaert, D.G., C.M. Testa, J.B. Penney, and A.B. Young (1993) Alternatively spliced isoforms of the NMDAR1 glutamate receptor: differential expression in the basal ganglia of the rat. Neurosci. Lett. 152:161-164.
50. Standaert, D.G., C.M. Testa, J.B. Penney, and A.B. Young (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. Comp. Neurol. 343:1-16.
51. Tecott, L.H., J.H. Eberwine, J. Barchas, and K.L. Valentine (1994) Methodological considerations in the utilization of in situ hybridization. In J. H. Eberwine, K. L. Valentino and J. Barchas (eds): In Situ Hybridization in Neurobiology. Oxford: Oxford University Press, pp. 3-23.
52. Turski, L., K. Bressler, K.-J. Rettig, P.-A. Loeschmann, and H. Wachtel (1991) NMDA antagonists protect nigral neurons in MPTP models of PD. Nature 349:414-418.
53. Uitti, R., A. Rajput, J. Ahlskog, K. Offord, D. Schroeder, M. Ho, M. Prasad, A. Rajput, and P. Basran (1996) Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology 46:1551-1556.
54. Ulas, J., F.B. Weihmuller, L.C. Brunner, J.N. Joyce, J.F. Marshall, and C.W. Cotman (1994) Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's/Alzheimer disease patients: An autoradiographic study. J. Neurosci. 14:6317-6324.
55. Vartanian, M., and P. Boxer (1996) Prevention of NMDA-induced brain injury in neonatal rats by subtype selective NMDA (NR2B) antagonists. Soc. Neurosci. Abstr. 22:1279.
56. Williams, K. (1995) Pharmacological properties of recombinant N-methyl-D-aspartate receptors containing the epsilon-4 (NR2D) subunit. Neurosci. Lett. 184:181-184.
57. 28k. Brain Res. 526:303-307.
58. Young, W.S., III, and M.J. Kuhar (1986) Quantitative in situ hybridization and determination of mRNA content. In G. R. Uhl (ed): In Situ Hybridization in Brain. New York: Plenum Press, pp. 243-248.
59. Zukin, R.S., and M.V.L. Bennett (1995) Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci. 18:306-313.